Package 0006-3026-02

Brand: keytruda

Generic: pembrolizumab
NDC Package

Package Facts

Identity

Package NDC 0006-3026-02
Digits Only 0006302602
Product NDC 0006-3026
Product ID 0006-3026_2224626f-467c-4655-828d-3dfc97fe41ac
Description

1 VIAL in 1 CARTON (0006-3026-02) / 4 mL in 1 VIAL (0006-3026-01)

Marketing

Marketing Status
Marketed Since 2015-01-15
Brand keytruda
Generic pembrolizumab
Sample Package No

Linked Drug Pages (1)

KEYTRUDA ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "2224626f-467c-4655-828d-3dfc97fe41ac", "openfda": {"nui": ["N0000191260", "N0000191259"], "unii": ["DPT0O3T46P"], "spl_set_id": ["9333c79b-d487-4538-a9f0-71b91a02b287"], "pharm_class_epc": ["Programmed Death Receptor-1 Blocking Antibody [EPC]"], "pharm_class_moa": ["Programmed Death Receptor-1-directed Antibody Interactions [MoA]"], "manufacturer_name": ["Merck Sharp & Dohme LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0006-3026-02)  / 4 mL in 1 VIAL (0006-3026-01)", "package_ndc": "0006-3026-02", "marketing_start_date": "20150115"}, {"sample": false, "description": "2 VIAL in 1 CARTON (0006-3026-04)  / 4 mL in 1 VIAL (0006-3026-01)", "package_ndc": "0006-3026-04", "marketing_start_date": "20190801"}], "brand_name": "KEYTRUDA", "product_id": "0006-3026_2224626f-467c-4655-828d-3dfc97fe41ac", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Programmed Death Receptor-1 Blocking Antibody [EPC]", "Programmed Death Receptor-1-directed Antibody Interactions [MoA]"], "product_ndc": "0006-3026", "generic_name": "pembrolizumab", "labeler_name": "Merck Sharp & Dohme LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "KEYTRUDA", "active_ingredients": [{"name": "PEMBROLIZUMAB", "strength": "25 mg/mL"}], "application_number": "BLA125514", "marketing_category": "BLA", "marketing_start_date": "20150115", "listing_expiration_date": "20271231"}